Canopy Growth Corporation (CGC)
| Market Cap | 240.61M -40.9% |
| Revenue (ttm) | 217.18M +10.7% |
| Net Income | -191.37M |
| EPS | -0.48 |
| Shares Out | 423.35M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,736,732 |
| Open | 0.5540 |
| Previous Close | 0.5738 |
| Day's Range | 0.5432 - 0.5800 |
| 52-Week Range | 0.5432 - 2.3800 |
| Beta | 2.44 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2026 |
About CGC
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-... [Read more]
Financial Performance
In fiscal year 2026, Canopy Growth's revenue was 284.60 million, an increase of 5.80% compared to the previous year's 269.00 million. Losses were -262.91 million, -48.34% less than in 2025.
Financial numbers in CAD Financial StatementsNews
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investors
International cannabis net revenue grew 141% year over year to $12.3 million. Cultivation yields have the potential to increase 25% to 30% in the Kincardine facility.
Canopy Growth price target lowered to C$1.25 from C$1.60 at Alliance Global
Alliance Global lowered the firm’s price target on Canopy Growth (CGC) to C$1.25 from C$1.60 and keeps a Neutral rating on the shares. The company’s fiscal Q2 report was slightly…
Canopy Growth (CGC) Q2 2027 Earnings Call Transcript
Margins slipped as Canadian medical reimbursement fell, even as revenue climbed.
Canopy Growth Q2 Earnings Call Highlights
Canopy Growth NASDAQ: CGC reported a 22% increase in fiscal second-quarter revenue as international cannabis sales more than doubled, and executives said the company remains on track to achieve positi...
Canopy Growth Corporation Reports Q2 FY2027 Financial Results with 22% Net Revenue Growth
Canopy Growth Corporation announced its financial results for the three months ended September 30, 2026, reporting consolidated net revenue of $81.4M, which represents a 22% increase compared to the t...
Canopy Growth Earnings Call Transcript: Q2 2027
Q2 revenue rose 22% YoY, led by cannabis and international growth, while Adjusted EBITDA loss narrowed QoQ. Management expects positive Adjusted EBITDA in H2 FY2027, with cultivation and network efficiencies building into FY2028.
Canopy Growth Quarterly report: Q2 2027
Canopy Growth has published its Q2 2027 quarterly earnings report on November 6, 2026.
Canopy Growth Earnings release: Q2 2027
Canopy Growth released its Q2 2027 earnings on November 6, 2026, summarizing the period's financial results.
Canopy Growth Earnings release: Q2 2027
Canopy Growth released its Q2 2027 earnings on November 6, 2026, summarizing the period's financial results.
Canopy Growth Report: Q2 2027
Canopy Growth published a report on November 6, 2026 containing material business information for investors and shareholders.
Canopy Growth MD&A: Q2 2027
Canopy Growth filed a regulatory document on November 6, 2026 disclosing important business information.
Canopy Growth Corporation Q2 Loss Increases
(RTTNews) - Canopy Growth Corporation (CGC) reported Loss for its second quarter of -C$40.69 million
Canopy Growth reports Q2 EPS (C$0.10) vs. (C$0.02) last year
Reports Q2 revenue C$99.5M vs. C$83M last year. “We have made tremendous progress on our international strategy. Our international business delivered 141% net revenue growth in the second quarter of…
Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
Tilray commands a 4x revenue advantage, but Canopy's latest quarter hints at momentum—here's what the data reveals about their competitive positioning.
Canopy Growth announces results of Annual General, Special Meeting
Canopy Growth (CGC) Corporation announced the voting results from its annual general and special meeting of shareholders convened on September 25, 2026, and adjourned to and reconvened on October 23.
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Canopy Growth Shareholders Approve Reverse Split Authority, Elect Board
Canopy Growth NASDAQ: CGC shareholders approved all matters presented at the company's reconvened 2026 Annual General and Special Meeting, including a share-consolidation authorization, the election o...
Canopy Growth Transcript: AGM 2026
Shareholders approved all ballot items, including director elections, the FY2027 auditor appointment and a potential 1-for-5 to 1-for-15 share consolidation before Oct. 23, 2027. They chose annual advisory compensation votes.
Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives throu...
Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth.
Despite last December's Executive Order, efforts to reschedule marijuana remained stymied by bureaucratic gridlock. Canopy Growth shares have tumbled on this regulatory inaction, but that's not the la...
Canopy Growth Proxy statement: Proxy filing
Canopy Growth filed a proxy statement on October 16, 2026, providing details for shareholder voting and corporate governance matters.
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
Canopy Growth maintains a strategic focus on premium cannabis products and European medical distribution. Tilray Brands has expanded into the craft beverage and wellness markets to diversify its reven...
Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market
Canopy Growth Corporation (CGC) closed at $0.71 in the latest trading session, marking a -6.27% move from the prior day.